Gosogliptin is a potent, orally active, highly selective and competitive inhibitor of DPP-4 (dipeptidyl peptidase 4), increasing the levels of intestinal glucagon peptide (GLP-1) and glucose-dependent proinsulinotropic polypeptide (GIP), thereby enhancing insulin secretion and lowering blood glucose levels. In animal studies, Gosogliptin rapidly, orally and reversibly inhibits plasma DPP-4 activity.
Molecular Weight:
366.41
Purity:
99.74%
CAS Number:
[869490-23-3]
Formula:
C17H24F2N6O
Target:
Proteasome|||DPP-4
T11450
T11450
* VAT and and shipping costs not included. Errors and price changes excepted
